The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory (R/R) B lymphoblastic leukemia/lymphoma (B-ALL).
 
Noam Edward Kopmar
No Relationships to Disclose
 
Kim Quach
No Relationships to Disclose
 
Ted Gooley
Consulting or Advisory Role - Kiadis Pharma; Pharmacyclics; Regimmune
 
Christen Martino
No Relationships to Disclose
 
Sindhu Cherian
No Relationships to Disclose
 
Mary-Elizabeth M. Percival
Research Funding - Ascentage Pharma (Inst); Astex Pharmaceuticals (Inst); Biosight (Inst); Celgene/Bristol-Myers Squibb (Inst); GlycoMimetics (Inst); Pfizer (Inst); Telios (Inst)
 
Anna B. Halpern
Consulting or Advisory Role - Abbvie; Agios; Notable labs
Research Funding - Bayer (Inst); disc medicine (Inst); Gilead/Forty Seven (Inst); Imago Pharma (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst)
 
Cristina Maria Ghiuzeli
No Relationships to Disclose
 
Vivian G. Oehler
Consulting or Advisory Role - Ascentage Pharma; Novartis; Pfizer
Research Funding - Pfizer
 
Janis Abkowitz
No Relationships to Disclose
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Abbvie; Adicet Bio; BerGenBio; BiolineRx; Bristol-Myers Squibb/Celgene/Juno; Genentech; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Kronos; Kura Oncology; Orum Therapeutics; Pfizer; Stemline Therapeutics
Research Funding - Amgen (Inst); Aptevo Therapeutics; Arog (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead; Kura Oncology; Macrogenics (Inst); Pfizer; Selvita (Inst)
 
Elihu Estey
No Relationships to Disclose
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene